🔥🐔 BizChicken 🐔🔥
Companies Similar to Third Harmonic Bio, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
BioAtla, Inc.
BA3011
Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.
Symbol: BCAB
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Jay M. Short Ph.D.
Sector: Healthcare
Employees: 65
Address: 11085 Torreyana Road, San Diego, CA 92121
Phone: 858 558 0708
Last updated: 2024-12-31
Dianthus Therapeutics, Inc.
DNTH103
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on designing, developing, and delivering novel monoclonal antibodies for severe autoimmune and inflammatory diseases. Their lead product, DNTH103, is in phase 1 clinical trials.
Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About
Symbol: DNTH
Recent Price: $21.50
Industry: Biotechnology
CEO: Mr. Marino Garcia M.B.A.
Sector: Healthcare
Employees: 53
Address: 7 Times Square, New York, NY 10036
Phone: 929-999-4055
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
HCW Biologics Inc.
HCW9218
HCW Biologics Inc. is a preclinical stage biopharmaceutical company that develops novel immunotherapies for chronic, low-grade inflammation and age-related diseases. Their lead products target various cancers, auto-immune, and metabolic diseases.
Symbol: HCWB
Recent Price: $0.43
Industry: Biotechnology
CEO: Dr. Hing C. Wong Ph.D.
Sector: Healthcare
Employees: 45
Address: 2929 North Commerce Parkway, Miramar, FL 33025
Phone: 954 842 2024
Last updated: 2024-12-31
Molecular Templates, Inc.
ETB Drug Platform
Molecular Templates, Inc. is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company develops therapies through its proprietary biologic engineered toxin body (ETB) drug platform.
Symbol: MTEM
Recent Price: $0.05
Industry: Biotechnology
CEO: Dr. Eric E. Poma Ph.D.
Sector: Healthcare
Employees: 62
Address: 9301 Amberglen Boulevard, Austin, TX 78729
Phone: 512 869 1555
Leadership
- Eric Poma, Ph.D., Chief Executive Officer & Chief Scientific Officer
- Jason Kim, President & Chief Financial Officer
- Kristen Quigley, Chief Operating Officer
- Grace Kim, Chief Strategy Officer & Head of Investor Relations
- Michelle Iwamoto-Fan, Ph.D., J.D., Senior Vice President and General Counsel
- Chris Moore, Ph.D., Senior Vice President and Head of Preclinical Development and Translational Medicine
- Joseph Phillips, Ph.D., Senior Vice President and Head of CMC Development
- Harold E. “Barry” Selick, Ph.D., Chairman of the Board
- David R. Hoffmann, Director
- Kevin M. Lalande, Founding Managing Director and Chief Investment Officer of Santé
- Gabriela Gruia, M.D., Director
- Corsee Sanders, Ph.D., Director
Last updated: 2024-12-31
Tourmaline Bio, Inc.
medicines for immune diseases
Tourmaline Bio, Inc. is a clinical biotechnology company focused on developing medicines for patients with life-altering immune diseases, such as Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED).
Symbol: TRML
Recent Price: $20.08
Industry: Biotechnology
CEO: Dr. Sandeep C. Kulkarni M.D.
Sector: Healthcare
Employees: 70
Address: 27 West 24th Street, New York, NY 10010
Phone: 646-481-9832
Last updated: 2024-12-31
180 Life Sciences Corp.
Therapeutics for chronic pain, inflammation, fibrosis, and inflammatory diseases
1180 Life Sciences Corp. is a clinical-stage biotechnology company focused on developing therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis, using platforms such as fibrosis and anti-TNF, synthetic CBD analogs, and a7n ACh R.
Symbol: ATNF
Recent Price: $2.98
Industry: Biotechnology
CEO: Mr. Lloyd Blair Jordan L.L.B., M.B.A.
Sector: Healthcare
Employees: 4
Address: Building 4, Palo Alto, CA 94306
Phone: 650 507 0669
Last updated: 2024-11-08
Belite Bio, Inc
LBS-008
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.
Symbol: BLTE
Recent Price: $61.97
Industry: Biotechnology
CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.
Sector: Healthcare
Employees: 20
Address: 5820 Oberlin Drive, San Diego, CA 92121
Phone: 858-246-6240
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
biote Corp.
Biote platform
biote Corp. operates in the hormone optimization space, offering a platform for Biote-certified practitioners to manage hormone imbalances and prescribe therapies. The company sells Biote-branded supplements and pellet insertion kits.
Symbol: BTMD
Recent Price: $5.91
Industry: Medical - Care Facilities
CEO: Ms. Teresa S. Weber
Sector: Healthcare
Employees: 194
Address: 1875 West Walnut Hill Lane, Irving, TX 75038
Phone: 844-604-1246
Last updated: 2024-12-31
Compass Therapeutics, Inc.
CTX-009, CTX-471, CTX-8371
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing antibody-based therapeutics to treat various human diseases. Their clinical stage products include investigational bispecific antibodies like CTX-009 and monoclonal antibodies such as CTX-471.
Symbol: CMPX
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Thomas J. Schuetz M.D., Ph.D.
Sector: Healthcare
Employees: 32
Address: 80 Guest Street, Boston, MA 02135
Phone: 617 500 8099
Last updated: 2024-12-31
Harvard Bioscience, Inc.
cellular and molecular technology instruments
Harvard Bioscience, Inc. develops, manufactures, and sells technologies and services that support research, discovery, and pre-clinical testing for drug development globally, offering a wide range of instruments for tissue and organ-based lab research.
About | Vision/Values | Leadership | Contact | About | Contact | Contact | Careers | About | About | About | About | About | About | About | About | About | About | About | Careers | About | About
Symbol: HBIO
Recent Price: $2.02
Industry: Medical - Instruments & Supplies
CEO: Mr. James W. Green
Sector: Healthcare
Employees: 391
Address: 84 October Hill Road, Holliston, MA 01746
Phone: 508 893 8999
Leadership
- James Green, Chairman, President & Chief Executive Officer
- Jennifer Cote, Chief Financial Officer and Treasurer
- John Fry, Chief Legal Counsel and Corporation Secretary
- Diane Houston, Vice President, Global IT
- Lori Packer, Vice President, Global People Operations
- Nitya Shetty, Vice President, Global Research and Development
- Ryan Wallace, Senior Vice President, Global Sales
Last updated: 2024-12-31
Hoth Therapeutics, Inc.
Various Therapeutic Treatments
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for unmet medical needs, including treatments for skin disorders, cancers, neuroinflammatory diseases, and more.
Symbol: HOTH
Recent Price: $0.76
Industry: Biotechnology
CEO: Mr. Robb Knie
Sector: Healthcare
Employees: 2
Address: 1 Rockefeller Plaza, New York, NY 10020
Phone: 646 756 2997
Leadership
- Robb Knie, Founder, President, and Chief Executive Officer
- David Briones, Chief Financial Officer
- Hayley Springer, Executive Vice President Operations
Last updated: 2024-12-31
Intensity Therapeutics, Inc.
INT230-6
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of cancer drugs for treating solid tumors. Their lead product, INT230-6, is undergoing Phase 2 trials for various cancers and is being tested in collaborations with major pharmaceutical companies.
Symbol: INTS
Recent Price: $1.82
Industry: Biotechnology
CEO: Mr. Lewis H. Bender M.A., M.B.A., M.S.
Sector: Healthcare
Employees: 5
Address: 61 Wilton Road, Westport, CT 06880
Phone: 203 221 7381
Leadership
- Lewis H. Bender, M.S., M.A., M.B.A., Founder and CEO
- Joseph Talamo, CPA, Chief Financial Officer
- James M. Ahlers, Executive Vice President
- Brian Schwartz, MD, Executive VP, Clinical Development
- John Wesolowski, CPA, MBA, Principal Accounting Officer and Controller
- Kimberly A. Guedes, RN, MBA, Vice President of Clinical Operations
- Doranne Frano, Regulatory Affairs and Quality Control
- Daniel J. Donovan, Board Member and Chief Executive Officer
- Tom Dubin, Board Member
- Mark A. Goldberg, MD, Board Member
- Emer Leahy, Ph.D., Board Member
Last updated: 2024-12-31
Peak Bio, Inc.
PHP-303
Peak Bio, Inc., based in Palo Alto, California, is a clinical-stage biopharmaceutical company focusing on developing therapeutics for oncology and inflammation, with a lead product candidate, PHP-303, for orphan disease Alpha1 anti-trypsin deficiency.
Symbol: PKBO
Recent Price: $0.07
Industry: Biotechnology
CEO: Dr. Hoyoung Huh M.D., Ph.D.
Sector: Healthcare
Employees: 6
Address: 3350 W Bayshore Rd., Palo Alto, CA 94303
Phone: 650-549-9103
Last updated: 2024-12-31
Synlogic, Inc.
Synthetic Biotic Medicines
Synlogic, Inc. is a clinical-stage biopharmaceutical company focused on the development of synthetic biotic medicines to treat metabolic and immunological diseases. The company's pipeline includes drug candidates for conditions such as phenylketonuria, homocystinuria, enteric hyperoxaluria, and solid tumors and lymphoma.
Symbol: SYBX
Recent Price: $1.40
Industry: Biotechnology
CEO: Mr. Antoine Awad
Sector: Healthcare
Employees: 6
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 401 9975
Last updated: 2024-12-31
Third Harmonic Bio, Inc.
THB001
Third Harmonic Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing medicine for allergic and inflammatory diseases, including THB001, an oral small-molecule KIT inhibitor for treating chronic urticaria and other indications.
Symbol: THRD
Recent Price: $10.38
Industry: Biotechnology
CEO: Ms. Natalie C. Holles
Sector: Healthcare
Employees: 42
Address: 300 Technology Square, Cambridge, MA 02139
Phone: 617-915-6680
Last updated: 2024-12-31
Theriva Biologics, Inc.
SYN-004, SYN-020, VCN-01
Theriva Biologics Inc. is a clinical-stage company developing therapeutics to address diseases with high unmet needs, including SYN-004 for preventing microbiome damage and SYN-020 for treating GI and systemic diseases.
Symbol: TOVX
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Steven A. Shallcross CPA
Sector: Healthcare
Employees: 22
Address: 9605 Medical Center Drive, Rockville, MD 20850
Phone: 301 417 4364
Last updated: 2024-12-31
IN8bio, Inc.
INB-200, INB-100, INB-400, INB-300
IN8bio, Inc. is a clinical-stage biotechnology company focused on gamma-delta T cell therapies for cancer treatment, with lead products in clinical trials and preclinical development.
Symbol: INAB
Recent Price: $0.27
Industry: Biotechnology
CEO: Mr. Tai-Wei Ho
Sector: Healthcare
Employees: 39
Address: 350 5th Avenue, New York, NY 10118
Phone: 646 600 6438
Last updated: 2024-12-31
Terns Pharmaceuticals, Inc.
TERN-101, TERN-201, TERN-501, TERN-601
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.
About | Contact | Careers | Careers | Careers | About | About | Careers | Culture | About | Leadership | About
Symbol: TERN
Recent Price: $7.15
Industry: Biotechnology
CEO: Ms. Amy L. Burroughs M.B.A.
Sector: Healthcare
Employees: 66
Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 525 5535
Last updated: 2024-11-08